Literature DB >> 15244090

Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.

M Varma1, A K Singla, S Dhawan.   

Abstract

The mucoadhesion, swelling, and drug release behavior of polyethylene oxide (PEO) and carbopol (CP) matrices were studied using a water soluble model drug diltiazem hydrochloride. The mucoadhesive strength of the matrices increased with increase in polymer content. The results showed that PEO was more mucoadhesive than CP. Mucoadhesion of the tablets was dependent upon the swelling. Swelling was ascertained by measuring the axial and radial expansion of matrix tablets following exposure to media of physiological ionic strength. There was a marked increase in the swelling index of matrices containing high polymer content of PEO as compared to CP. Drug release kinetics were found to be closely related to dissolution and swelling properties of the matrices. The release was found to be non-Fickian with n (release exponent) values ranging from 0.45-0.58. At a constant polymer content (15.84% w/w), the main contributing factor for the mucoadhesion, swelling, and release was the amount of PEO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15244090     DOI: 10.1081/ddc-120037485

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Use of Placket-Burman statistical design to study effect of formulation variables on the release of drug from hot melt sustained release extrudates.

Authors:  Satishkumar P Jain; Pirthi Pal Singh; Sharad Javeer; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2010-05-28       Impact factor: 3.246

2.  Characterization of Heterogeneity and Spatial Distribution of Phases in Complex Solid Dispersions by Thermal Analysis by Structural Characterization and X-ray Micro Computed Tomography.

Authors:  Muqdad Alhijjaj; Samy Yassin; Mike Reading; J Axel Zeitler; Peter Belton; Sheng Qi
Journal:  Pharm Res       Date:  2016-04-19       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.